Alger Life Sciences Innovation Fund LP — Form D/A
Alger Life Sciences Innovation Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-04-10. $30.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-04-10
- Form: D/A
- Accession: 0001923614-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $30.3M
- Minimum investment: $500K
- Investors: 13
- Security types: fund interests
- SEC file number: 021-442344
Issuer
- Name: Alger Life Sciences Innovation Fund LP
- CIK: 0001923614
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 100 PEARL STREET, 27TH FLOOR 27th Floor, NEW YORK, NY, 10004
- Phone: 212-806-8800
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Daniel Cayley Chung | Related Person | New York, NY |
| Robert Louis Kincel | Related Person | New York, NY |
| Hal Liebes | Related Person | New York, NY |
| Hal Cayley Liebes | Director | New York, NY |
| Hal Cayley Liebes | Executive Officer | New York, NY |
| Daniel Cayley Chung | Director | New York, NY |
| Daniel Cayley Chung | Executive Officer | New York, NY |
| Robert Louis Kincel | Director | New York, NY |
| Robert Louis Kincel | Executive Officer | New York, NY |
| N/A Fred Alger Management, LLC | Promoter | New York, NY |
| N/A Alger Alternative Holdings II, LLC | Promoter | New York, NY |
Other filings by this issuer (4)
More